{{Rsnum
|rsid=8047395
|Gene=FTO
|Chromosome=16
|position=53764611
|Orientation=plus
|GMAF=0.4077
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FTO
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.3 | 52.3 | 15.4
| HCB | 42.2 | 42.2 | 15.6
| JPT | 46.7 | 37.8 | 15.6
| YRI | 58.7 | 38.1 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 42.2 | 42.2 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20819567
|Title=The association between common genetic variation in the FTO gene and metabolic syndrome in Han Chinese
}}

{{PMID|19322589|OA=1
}} Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.

{{PMID|19374514|OA=1
}} Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines.

{{PMID|21102551}} Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}